CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Human glioblastoma arises from subventricular zone cells with low-level driver mutations
Authors
Eui Hyun Kim
Jee Ye Kahng
+17 more
Jeong Eun Lee
Jeong Ho Lee
Ji-Hyun Lee
Ji-Yong Um
Jong Hee Chang
Joo Ho Lee
Joon-Hyuk Lee
Jun Sung Park
June-Koo Lee
Junseong Park.
Se Hoon Kim
Seok-Gu Kang
Seon Jin Yoon
Sung-Hong Park
Won-Suk Chung
Woo Kyeong Kim
Young Seok Ju
Publication date
1 August 2018
Publisher
NATURE PUBLISHING GROUP
Abstract
Glioblastoma (GBM) is a devastating and incurable brain tumour, with a median overall survival of fifteen months1,2. Identifying the cell of origin that harbours mutations that drive GBM could provide a fundamental basis for understanding disease progression and developing new treatments. Given that the accumulation of somatic mutations has been implicated in gliomagenesis, studies have suggested that neural stem cells (NSCs), with their self-renewal and proliferative capacities, in the subventricular zone (SVZ) of the adult human brain may be the cells from which GBM originates3–5. However, there is a lack of direct genetic evidence from human patients with GBM4,6–10. Here we describe direct molecular genetic evidence from patient brain tissue and genome-edited mouse models that show astrocyte-like NSCs in the SVZ to be the cell of origin that contains the driver mutations of human GBM. First, we performed deep sequencing of triple-matched tissues, consisting of (i) normal SVZ tissue away from the tumour mass, (ii) tumour tissue, and (iii) normal cortical tissue (or blood), from 28 patients with isocitrate dehydrogenase (IDH) wild-type GBM or other types of brain tumour. We found that normal SVZ tissue away from the tumour in 56.3% of patients with wild-type IDH GBM contained low-level GBM driver mutations (down to approximately 1% of the mutational burden) that were observed at high levels in their matching tumours. Moreover, by single-cell sequencing and laser microdissection analysis of patient brain tissue and genome editing of a mouse model, we found that astrocyte-like NSCs that carry driver mutations migrate from the SVZ and lead to the development of high-grade malignant gliomas in distant brain regions. Together, our results show that NSCs in human SVZ tissue are the cells of origin that contain the driver mutations of GBM. © 2018, Springer Nature Limite
Similar works
Full text
Available Versions
IBS Publications Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:pr.ibs.re.kr:8788114/5476
Last time updated on 06/02/2020